首页 | 本学科首页   官方微博 | 高级检索  
检索        

法国与加拿大药品监管机构设置与启示
引用本文:张昊,董铎,程刚.法国与加拿大药品监管机构设置与启示[J].中国药物警戒,2013,10(9):536-539,542.
作者姓名:张昊  董铎  程刚
作者单位:1. 沈阳药科大学工商管理学院,辽宁沈阳,110016
2. 国家食品药品监督管理总局药品评价中心,北京,100045
摘    要:药品监管机构是实施市场监管的主体,其设置模式与监管组织体系直接影响着政府监管的效率和药品市场的发展活力.本文以法国与加拿大的药品监管机构为研究对象,通过查阅两国药品监管官方网站和相关文献,对药品监管局的责任主体、组织机构和监管人员等方面进行了归纳总结,并与我国药监机构设置与职能进行了深入的比较,为我国药品监管体系的建设与发展提供了意见与建议.

关 键 词:法国  加拿大  药品监管机构  启示

France and Canada Drug Regulatory Agencies and Implication
ZHANG Hao , DONG Duo , CHENG Gang.France and Canada Drug Regulatory Agencies and Implication[J].Chinese JOurnal of Pharmacovigilance,2013,10(9):536-539,542.
Authors:ZHANG Hao  DONG Duo  CHENG Gang
Institution:1School of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China; 2Center for Drug Reevaluation, CFDA, Beijing 100045, China)
Abstract:Drug regulatory agency is the main body of implementing market regulation, the setting pattern and organizational system directly affects the efficiency of government regulation and the development of the pharmaceutical market's vitality. In this article France and Canada drug regulatory agencies were selected the research object. By searching their drug regulatory official websites and related literatures, we summarized the main responsibility of the drug administration, organization and supervisor and compared with drug regulatory institution setting and function of our country. The comments and suggestions were put forward for the construction and development of China's drug regulatory system
Keywords:France  Canada  regulatory agency  implication
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号